WAVE@home brings you a series of free 60 – 90 minute webcasts on Sundays from late March, featuring highly-regarded speakers who had been scheduled to speak at WAVE 2020.
Dr Lauren Ayton will cover the 3 presentations she was due to give at WAVE 2020 Conference. You can watch this recording of her 90 minute webcast, with optional assessment for the full 3 CPD under Independent Learning.
Classification and Risk Prediction in Age-Related Macular Degeneration
Historically, the classification of AMD was unclear, with various schemes being used around the globe. Since 2014, the internationally accepted scheme has been the Beckman classification, which will be reviewed in this talk. We will then discuss how the Beckman classification can provide information on the risk of progression and direct your patient management.
Imaging in AMD: New Signs to Know
The era of multi-modal imaging in optometry is here, and we now have access to advanced techniques such as near-infrared photography and optical coherence tomography in many practices. At the same time, medical research studies utilising these technologies are discovering a multitude of new imaging biomarkers, and explanations for the strange images that we sometimes see in clinic. The aim of this talk is to update optometrists on new, clinically relevant imaging biomarkers of AMD.
Advanced Therapeutics: Ocular Gene Therapy Now, and in The Future
The past few years have seen significant progress on the development of “advanced therapeutics” for vision disorders, such as stem cells, brain-machine interface implants and gene therapy. This talk will focus on the current status of gene therapy for conditions such as inherited retinal degenerations, glaucoma and age-related macular degeneration.
Dr Lauren AytonShow details
Dr Lauren Ayton - BOptom PhD GCOT FAAO FACO
Dr Lauren Ayton is a clinician-scientist with research interests in retinal disease, low vision and vision restoration. After completing her professional training in Optometry and a PhD at the University of Melbourne, Dr Ayton completed postdoctoral training in the area of ocular motor assessment in traumatic brain injury. She then took a position at the Centre for Eye Research Australia, where she was the Bionic Eye Clinical Team Leader and worked on a number of projects in age-related macular degeneration.
Between 2017 and 2019, Dr Ayton was the Director of Clinical and Regulatory Affairs at Bionic Eye Technologies, Inc., a USA start-up company affiliated with Harvard and Cornell Universities. This experience cemented Dr Ayton’s passion for research innovation and entrepreneurship. Dr Ayton is now a Director of SPARK Melbourne, a University-led research incubator and industry mentoring program that originated from Stanford University.
In 2017, Dr Ayton was awarded a NHMRC Fellowship to translate her research in age-related macular degeneration to practicing clinicians. With long-time collaborator, Prof Robyn Guymer, Dr Ayton is currently working on ways to communicate the most recent research findings in AMD to optometrists, including information on risk assessment, imaging biomarkers and management strategies. Dr Ayton returned to the University of Melbourne in 2019 and is now the Head of the Vision Optimisation Unit within the Departments of Optometry and Vision Science, and Surgery (Ophthalmology). Dr Ayton is currently a NHMRC Medical Research Future Fund Next Generation Clinical Fellow and a Driving Research Momentum Fellow at the University of Melbourne.